Search results for “Treprostinil” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 691 patents, we discovered top 43 key players by total patent application. United Therapeutics Corp., Eli Lilly & Co., Insmed, Inc. are dominant in this area. They take 57.31% of the total patent filing.
United Therapeutics Corp.
United States
Patent: 263
Eli Lilly & Co.
Indiana, United States
Patent: 70
Insmed, Inc.
New Jersey, United States
Patent: 63
Corsair Pharma, Inc.
California, United States
Patent: 55
SciPharm Sàrl
Grevenmacher, Luxembourg
Patent: 42
Chirogate International, Inc.
Taiwan Province, China
Patent: 19
Ascendis Pharma GmbH
Germany
Patent: 15
Pharmosa Biopharm Inc.
Taiwan Province, China
Patent: 14
Liquidia Technologies, Inc.
North Carolina, United States
Patent: 12
MannKind Corp.
California, United States
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 221 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing United Therapeutics Corp., Insmed, Inc., Corsair Pharma, Inc. take 43.89% of patent filing during this period.
United Therapeutics Corp.
United States
Patent: 51
Insmed, Inc.
New Jersey, United States
Patent: 26
Corsair Pharma, Inc.
California, United States
Patent: 20
Eli Lilly & Co.
Indiana, United States
Patent: 19
Chirogate International, Inc.
Taiwan Province, China
Patent: 18
Pharmosa Biopharm Inc.
Taiwan Province, China
Patent: 14
MannKind Corp.
California, United States
Patent: 8
Jiangsu Zhongqiang Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Liquidia Technologies, Inc.
North Carolina, United States
Patent: 6
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 221 patents in last 5 years, we discover 14 new entrants. Pharmosa Biopharm Inc., MannKind Corp., Jiangsu Zhongqiang Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Pharmosa Biopharm Inc.
Taiwan Province, China
Patent: 14
MannKind Corp.
California, United States
Patent: 8
Jiangsu Zhongqiang Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 4
Nanomi BV
Overijssel, Netherlands
Patent: 3
Zhaoke Pharmaceutical (Guangzhou) Ltd.
Guangdong Sheng, China
Patent: 3
Guangzhou Kaishi Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 2
Guangzhou Kaishi Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 2
Radiometer A/S
Hovedstaden, Denmark
Patent: 1
Fundación Universitaria San Pablo CEU
Madrid, Spain
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 8 patents, we discovered top 4 universities and scientific research institutions by total patent application. Grenoble University Hospital, Université Joseph Fourier, University of Grenoble are dominant in this area. They take 112.50% of the total patent filing.
Grenoble University Hospital
France
Patent: 4
Université Joseph Fourier
France
Patent: 3
University of Grenoble
France
Patent: 2
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: